Pharmafile Logo
Pharmafocus logo
Advanced Search

Witty

Showing 15 posts of 30 posts found.

gsk image

GSK to make ‘fundamental changes’

February 6, 2014
Sales and Marketing China, GSK, Tafinlar, Witty, q4, results

GlaxoSmithKline has pledged to make ‘fundamental changes’ to the manner in which it does business, looking at its interaction with …

News
gsk_china_1

China ban for corrupt pharma firms

January 2, 2014
Medical Communications, Sales and Marketing Cameron, China, GSK, Witty, bribery, lilly

News
GSK image

GSK changes sales tactics

December 17, 2013
Medical Communications, Sales and Marketing GSK, Witty, bribery, corruption, cuts, sales, transparency

GlaxoSmithKline is to remove individual staff sales targets and end doctor payments for activities that promote its products.  The UK …

News
gsk image

Witty goes to China

December 3, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery

GlaxoSmithKline chief executive Sir Andrew Witty has embarked on a potentially delicate diplomatic mission as part of a UK trade …

News
GSK image

Actions in China ‘shameful’ says GSK boss

July 25, 2013
Medical Communications, Sales and Marketing China, GSK, Witty, bribery

GlaxoSmithKline has admitted that allegations of corruption at its China business are ‘shameful’ and will seek out its cause. Speaking …

News
gsk image

GSK sales up – impact of China allegations to follow

July 24, 2013
Sales and Marketing GSK, Q2, Seretide, Seroxat, Witty, bribery, transparency

GlaxoSmithKline has reported a modest rise in sales but the fallout from China’s bribery probe dominates the firm’s release of …

News
Sanofi image

Sanofi chief executive to lead EFPIA

June 26, 2013
Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty

Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …

News
Witty image

GSK’s Witty: ‘Drugs should be cheaper’

March 15, 2013
Manufacturing and Production, Research and Development, Sales and Marketing ABPI, GSK, Witty

Drugs should be cheaper, GlaxoSmithKline boss Sir Andrew Witty said at a conference this week. His comments, reported by Reuters, …

News
GSK image

GSK plans greater use of biocatalysis, continuous processing

February 19, 2013
Manufacturing and Production GSK, Witty, biocatalysis

GlaxoSmithKline says it is turning to technology to help improve the cost efficiency of its manufacturing operations, including greater use …

News
andrew_witty_gsk

GlaxoSmithKline announces Board changes

September 27, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Witty

GlaxoSmithKline has announced several changes to its Board and Committee structure. The GSK Board of directors with effect from 1 …

Appointment

GSK falters in Q2 as austerity measures bite

July 25, 2012
Sales and Marketing Benylsta, GSK, Q2, Seretide, Witty

GlaxoSmithKline posted a loss in its second quarter results, as pressure in mature markets continues to affect the firm. Pharmaceutical …

News

GSK to pay ‘unprecedented’ $3 billion fraud charge

July 3, 2012
Business Services, Sales and Marketing Avandia, Bextra, GSK, Paxil, Wellbutrin, Witty

GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history. The charges relate to …

News
Witty image

Witty warns EU leaders over pricing

June 27, 2012
Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing

Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …

News

Europe’s pharma sector : living through the crisis

March 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma

Pharmaceutical markets across Europe have been badly hit by the economic crisis, with revenues in some countries being decimated by …

Feature
GSK picture

GSK posts strong underlying sales growth

February 8, 2012
Research and Development, Sales and Marketing Avodart, GSK, R&D, Seretide, Witty, rotarix

GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead.  The UK firm saw 4% …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025